Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nuclear Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NUCMEDBIO.2005.09.002PMID 16459269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.

  2005cited by this paper
• Structural requirements for in vivo detection of cell death with 99mTc-annexin V.

  2005cited by this paper
• The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5.

  2004cited by this paper
• Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy.

  2004cited by this paper
• Optimal Modification of Annexin V with Fluorescent Dyes

  2004cited by this paper
• Apoptosis-detecting radioligands: current state of the art and future perspectives

  2004cited by this paper
• Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use.

  2003cited by this paper
• Vasopressin V2 receptor antagonists.

  2002cited by this paper
• Monitoring apoptosis in real time.

  2002cited by this paper
• Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.

  2002cited by this paper
• Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm

  2001cited by this paper
• Localization of annexin V in rat normal kidney and experimental glomerulonephritis

  2001cited by this paper
• Plasma protein binding of (99m)Tc-labeled hydrazino nicotinamide derivatized polypeptides and peptides.

  2001cited by this paper
• Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc.

  2000cited by this paper
• Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA

  2000cited by this paper
• Inflammation and infection imaging with a 99mTc-neutrophil elastase inhibitor in monkeys.

  2000cited by this paper
• Purification and characterization of 40-kDa sterigmatocystin O-methyltransferase involved in aflatoxin biosynthesis.

  1999cited by this paper
• Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.

  1999cited by this paper
• Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence

  1999cited by this paper
• Imaging of apoptosis (programmed cell death) with 99mTc annexin V.

  1999cited by this paper
• Comparison of the stability of technetium-labeled peptides to challenge with cysteine.

  1999cited by this paper
• Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.

  1999cited by this paper
• Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.

  1998cited by this paper
• The influence of temperature and alkaline pH on the labeling of free and conjugated MAG3 with technetium-99m.

  1997cited by this paper
• Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.

  1997cited by this paper
• 99mTc labeling of highly potent small peptides.

  1997cited by this paper
• Labeling a Hydrazino Nicotinamide-Modified Cyclic IIb/IIIa Receptor Antagonist with 99mTc Using Aminocarboxylates as Coligands

  1996cited by this paper
• Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.

  1996cited by this paper
• Comparative evaluation of 99Tcm-Hynic‐HSA and 99Tcm-MAG3‐HSA as possible blood pool agents

  1995cited by this paper
• Effect of "co-ligand" on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides.

  1995cited by this paper
• Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?

  1994cited by this paper
• The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.

  1992cited by this paper
• Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers.

  1990cited by this paper
• Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.

  1990cited by this paper
• Technetium and rhenium in chemistry and nuclear medicine

  1990cited by this paper

• Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m

  2024cites this paper
• Albumin Glycation Affects the Delivery of C-Peptide to the Red Blood Cells

  2022cites this paper
• Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis

  2019cites this paper
• Stability evaluation of Tc-99m radiolabeled GRPr antagonist with amino acid chelators

  2018cites this paper
• Imaging, biodistribution and in vitro study of smart 99mTc-PAMAM G4 dendrimer as novel nano-complex.

  2017cites this paper
• Apoptosis imaging by radionuclide probes

  2017cites this paper
• Effective way to radiolabel the peptide of MAG3–RM26 with 188Re and the study on its coordination chemistry

  2017cites this paper
• Coordination investigation of rhenium with MAG3 using LC-MS and UV spectrometer and the simple radiolabelling process

  2016cites this paper
• Preparation and Evaluation of 99mTc‐labeled anti‐CD11b Antibody Targeting Inflammatory Microenvironment for Colon Cancer Imaging

  2015cites this paper
• Molecular Imaging of Apoptosis: From Micro to Macro

  2015cites this paper
• Preliminary Biological Evaluation of 18F-FBEM-Cys-Annexin V a Novel Apoptosis Imaging Agent

  2015cites this paper
• Labeling and Imaging Techniques for Quantification of Therapeutic Biologics

  2015cites this paper
• Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.

  2015cites this paper
• Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development

  2015cites this paper
• Kit formulation for 99mTc-labeling of recombinant Annexin V molecule with a C-terminally engineered cysteine

  2014cites this paper
• Single-photon emission computed tomography tracers for predicting and monitoring cancer therapy.

  2014cites this paper
• Comparison of the InVivo Distribution of Four Different Annexin A 5 Adducts in

  2014cites this paper
• Untersuchungen zur Etablierung CEACAM1-bindender Partikel für die bildgebende Diagnostik des Prostatakarzinoms

  2014cites this paper
• Library Synthesis, Screening, and Discovery of Modified Zinc(II)-Bis(dipicolylamine) Probe for Enhanced Molecular Imaging of Cell Death

  2014cites this paper
• Synthesis , Screening , and Discovery of Modi fi ed Zinc ( II )-Bis ( dipicolylamine ) Probe for Enhanced Molecular Imaging of Cell Death

  2014cites this paper
• Preliminary Biological Evaluation of Novel 99mTc-Cys-Annexin A5 as a Apoptosis Imaging Agent

  2013cites this paper
• Highly Specific PET Imaging of Prostate Tumors in Mice with an Iodine-124-Labeled Antibody Fragment That Targets Phosphatidylserine

  2013cites this paper
• Tissue Distribution Studies of Protein Therapeutics Using Molecular Probes: Molecular Imaging

  2012cites this paper
• Biodistribution of 99mTc Tricarbonyl Glycine Oligomers

  2012cites this paper
• Chelating systems for (99m)Tc/(188)Re in the development of radiolabeled peptide pharmaceuticals.

  2012cites this paper
• Multicolor fluorescence imaging of traumatic brain injury in a cryolesion mouse model.

  2012cites this paper
• Comparison of the In Vivo Distribution of Four Different Annexin A5 Adducts in Rhesus Monkeys

  2011cites this paper
• In vivo optical imaging of acute cell death using a near-infrared fluorescent zinc-dipicolylamine probe.

  2011cites this paper
• Small-Animal PET of Tumor Damage Induced by Photothermal Ablation with 64Cu-Bis-DOTA-Hypericin

  2011cites this paper
• Peptide-based imaging agents targeting phosphatidylserine for the detection of apoptosis.

  2011cites this paper
• In Vivo Imaging of Apoptosis in Oncology: An Update

  2011cites this paper
• In vivo targeting of cell death using a synthetic fluorescent molecular probe

  2011cites this paper
• Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators.

  2011cites this paper
• (99m)Tc-radiolabelled peptides for tumour imaging: present and future.

  2010cites this paper
• A Review of Imaging Agent Development

  2009cites this paper
• Cell-permeable [99mTc(CO3)]-labeled fluorogenic caspase 3 substrate for dual-modality detection of apoptosis.

  2009cites this paper
• In vivo apoptosis imaging agents and strategies.

  2009cites this paper
• Molecular imaging of apoptosis with radio-labeled Annexin A5 focused on the evaluation of tumor response to chemotherapy.

  2009cites this paper
• Avaliação da radiomarcação da anexina A5 com Tecnécio-99m: influência do método de marcação nas propriedades físicos-químicas e biológicas do composto

  2009cites this paper
• Site-specifically modified fusion proteins for molecular imaging.

  2008influential citation
• Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.

  2008cites this paper
• In Vivo Detection of Apoptosis

  2008cites this paper
• In vivo imaging of apoptosis

  2008cites this paper
• Monitoring of treatment-induced apoptosis in oncology with PET and SPECT.

  2008cites this paper
• An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with 99mTc at room temperature

  2007cites this paper
• In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules.

  2007cites this paper
• The imaging continuum: bench to biomarkers to diagnostics

  2007cites this paper
• 99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule

  2007cites this paper
• Intraoperative Detection of Cell Injury and Cell Death with an 800 nm Near‐Infrared Fluorescent Annexin V Derivative

  2006cites this paper
• Clinical trials in a molecular world.

  2006cites this paper
• Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods.

  2006cites this paper
• Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules

  2006cites this paper
• Survey of the year 2003 commercial optical biosensor literature

  2005cites this paper